BLOSSOM CGM

This prospective cohort study looks at incidence and severity of hypoglycemia in dialysis patients through use of a continuous glucose monitoring (CGM) device. The study aims to enroll up to 600 participants, along with non-dialysis control subjects. Patients undergoing hemodialysis or peritoneal dialysis for kidney failure are eligible for enrollment.